• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SmileDirectClub Reports First Quarter 2023 Financial Results

    5/9/23 4:01:00 PM ET
    $SDC
    Medical/Dental Instruments
    Health Care
    Get the next $SDC alert in real time by email

    NASHVILLE, Tenn., May 09, 2023 (GLOBE NEWSWIRE) -- SmileDirectClub, Inc. (NASDAQ:SDC), the next generation oral care company with the first medtech platform for teeth straightening, today announced its financial results for the first quarter ended March 31, 2023. Revenue for the first quarter of 2023 increased 38.4% compared to the fourth quarter of 2022 with gross profit up 64.6% for the same period.

    For the first quarter 2023, disciplined cost management allowed the Company to deliver a $7 million improvement in Net Loss and an $8 million improvement in Adjusted EBITDA compared to the first quarter of 2022 despite a decline in revenue year-over-year. Net Cash used in operating activities decreased $29 million, driving a $36 million improvement in free cash flow in the quarter compared to the first quarter of 2022. The leverage that SmileDirectClub has built in its operating model reflects a more efficient organization that is better positioned to achieve profitability and execute at a high level on the Company's mission to democratize access to a smile each and every person loves by making it affordable and convenient for everyone.

    First Quarter 2023 Financial Highlights

    • Total revenue of $120 million, a 38.4% increase from the fourth quarter of 2022.
    • Net loss of $(66) million, a $4 million improvement from the fourth quarter of 2022 and an improvement of $7 million over the prior year period.
    • Adjusted EBITDA of $(26) million, a $21 million improvement over the fourth quarter of 2022, and an improvement of $8 million over the prior year period.
    • Diluted EPS of $(0.16), a $0.02 improvement from the fourth quarter of 2022, and an improvement of $0.03 over the prior year period.
    • Net cash used in operating activities was $(33) million, a decrease of $19 million over the fourth quarter of 2022 and a decrease of $29 million over the prior year period.
    • Free Cash Flow defined as net cash used in operating activities less net cash used in investing activities of $(41) million, an improvement of $23 million from the fourth quarter of 2022 and an improvement of $36 million over the prior year period.

    Key Operating Metrics and Strategic Highlights

    • First quarter unique aligner shipments of 59,645, a 43.9% sequential increase over 41,462 shipments in the fourth quarter of 2022.
    • First quarter average aligner gross sales price ("ASP") of $1,949 compared to $1,960 for the fourth quarter of 2022.
    • Negotiations with certain holders of convertible notes issued in 2021 have progressed with respect to a potential transaction.

    "We delivered financial results and completed operating benchmarks positioning us well to achieve our full year financial outlook," said David Katzman, Chief Executive Officer and Chairman of SmileDirectClub. "Our core business continued to perform well despite the continuing macroeconomic challenges, and we have progressed on our key growth initiatives with the successful launch of our hybrid in-person and remote premium aligner product, SmileDirectClub CarePlus, in four key U.S. pilot markets. This initial launch has been well received, and we are planning the second wave of additional markets by the end of the third quarter. Additionally, our innovative SmileMaker mobile scanning app for 3D treatment planning continues to perform well in Australia, and we remain on target to release SmileMaker in the U.S in the next two weeks. We are also tracking on our path to achieving EBITDA profitability in the third quarter and positive cash flow run rates by the end of the year. We remain optimistic on our business outlook for 2023 and beyond."

    Business Outlook

    SmileDirectClub's mission is to democratize access to a smile each and every person loves by making it affordable and convenient for everyone. The aspirational vision of the Company's organization is to become the "world's leading oral health brand by helping more people realize the life changing potential of a confident smile." SmileDirectClub's vision and mission are much greater than manufacturing and marketing clear aligners. Every decision and investment the Company has made is to support and expand this mission and enable its long-term growth potential. For SmileDirectClub to realize the Company's vision through its mission, the Company must expand its reach within and beyond the Company's existing core customer base. Expanding reach comes through continuously bringing transformative innovation to the market across an entire portfolio of both consumer facing and non-consumer facing innovations, including the Company's SmileMaker mobile scanning app for 3D treatment planning, its hybrid aligner offering CarePlus, the SmileDirectClub Partner Network, aligner product innovations, and oral care solutions, including our industry leading whitening and flosser products. SmileDirectClub possesses the unique assets and innovation to disrupt the incumbents, the agility to adjust to the needs of our customers, and a sustainable brand that is top of mind with consumers.  

    The Company has been issued 47 patents and counting for its innovations in orthodontic treatment planning, aligner manufacturing, smile scanning technologies, its proprietary telehealth platform and a variety of other areas. There are many more patents pending in the pipeline in both the U.S. and abroad on various technologies relating to data capture, 3D image capture, intraoral scanning, monitoring, manufacturing, and consumer products. In addition, the Company has enabled treatment for over 1.9 million customers, built the only end-to-end vertically integrated platform for the consumer at scale, created a dental Partner Network with over 1,000 global practices that are live or pending training, delivered oral care products available at over 16,300 retail stores worldwide, and remains the strongest teledentistry brand with continued high brand awareness.

    When consumers are considering straightening their teeth, they typically do one or all of the following: search online to understand their options; ask a dentist; ask a friend or family member which option they should choose. Based on the Company's research, consumers have noted its product and customer experience is nearly identical to Invisalign, less expensive, and more convenient. Compared to other teledentistry platforms, research showed that significantly fewer customers would recommend those brands to their friends and family compared with SmileDirectClub customer recommendations. A 2022 consumer brand survey separately noted that SmileDirectClub's unaided and aided brand awareness continues to increase from and surpass its teledentistry competitors and close in on the brand awareness recognition of category originator Invisalign. Additionally, the Company's pioneering telehealth platform was recently recognized by MedTech Breakthrough, winning the "Best Telehealth Platform" award in 2022.

    In addition to these investments to create the next generation of oral care and influence consumer decision making, the Company will continue to make strategic investments in penetrating new demographics to drive controlled growth, while also executing against its profitability goals. Lastly, favorable industry dynamics continue to increase with broader acceptance of telehealth, and specifically teledentistry, minimal penetration against the total addressable market, a number of recent regulatory wins that helped remove barriers to access to care, and clear aligners gaining share in the overall industry.

    As disclosed in a recent 8K filing at the end of March, SmileDirectClub's leadership team has been negotiating with certain of the holders of its convertible notes that were issued in 2021.  SmileDirectClub is pleased to inform its investors that those negotiations have progressed with respect to a potential transaction.  We anticipate being able to share more in the very near term. Any financing transaction the Company would enter into will be focused on improving our capital structure by bringing in additional funding and lowering our overall debt.

    Full Year 2023 Guidance

    The Company reaffirmed its guidance as well as its assumptions underlying that guidance for the year ended December 31, 2023, previously provided on February 28, 2023.

    Conference Call Information

    SmileDirectClub First Quarter 2023 Conference Call Details
      
    Date:May 10, 2023
    Time:8:00 a.m. Eastern Time (7:00 a.m. Central Time)
    Dial-In: 1-877-407-9208 (domestic) or 1-201-493-6784 (international)
    Webcast: Visit "Events and Presentations" section of the company's IR page at http://investors.smiledirectclub.com

    A replay of the call may be accessed the same day from 11 a.m. Eastern Time on Wednesday, May 10, 2023 until 11:59 p.m. Eastern Time on Wednesday, May 24, 2023 by dialing 1-844-512-2921 (domestic) or 1-412-317-6671 (international) and entering the replay PIN: 13737531. A copy of the first quarter results supplemental earnings presentation and an archived version of the call, when completed, will also be available on the Investor Relations section of SmileDirectClub's website at investors.smiledirectclub.com.

    Forward-Looking Statements

    This earnings release contains forward-looking statements. All statements other than statements of historical facts may be forward-looking statements. Forward-looking statements generally relate to future events and include, without limitation, projections, forecasts and estimates about possible or assumed future results of our business, financial condition, liquidity, results of operations, plans, and objectives. Some of these statements may include words such as "expects," "anticipates," "believes," "estimates," "targets," "plans," "potential," "intends," "projects," and "indicates."

    Although they reflect our current, good faith expectations, these forward-looking statements are not a guarantee of future performance, and involve a number of risks, uncertainties, estimates, and assumptions, which are difficult to predict. Some of the factors that may cause actual outcomes and results to differ materially from those expressed in, or implied by, the forward-looking statements include, but are not necessarily limited to: the current noncompliance with the minimum bid requirement pursuant to the Nasdaq Listing Rules; our ability to consummate our convertible note exchange and secure additional financing, the duration and magnitude of the COVID-19 pandemic and related containment measures; our management of growth; the execution of our business strategies, implementation of new initiatives, and improved efficiency; our sales and marketing efforts; our manufacturing capacity, performance, and cost; our ability to obtain future regulatory approvals; our financial estimates and needs for additional financing; consumer acceptance of and competition for our clear aligners; our relationships with retail partners and insurance carriers; our R&D, commercialization, and other activities and expenditures; the methodologies, models, assumptions, and estimates we use to prepare our financial statements, make business decisions, and manage risks; laws and regulations governing remote healthcare and the practice of dentistry; our relationships with vendors; the security of our operating systems and infrastructure; our risk management framework; our cash and capital needs; our intellectual property position; our exposure to claims and legal proceedings; and other factors described in our filings with the Securities and Exchange Commission, including but not limited to our Annual Report on Form 10-K for the year ended December 31, 2022.

    About SmileDirectClub

    SmileDirectClub, Inc. (NASDAQ:SDC) ("SmileDirectClub") is an oral care company and creator of the first medtech platform for teeth straightening. Through its cutting-edge telehealth technology and vertically integrated model, SmileDirectClub is revolutionizing the oral care industry. SmileDirectClub's mission is to democratize access to a smile each and every person loves by making it affordable and convenient for everyone. SmileDirectClub is headquartered in Nashville, Tennessee, USA.  For more information, please visit SmileDirectClub.com.

    Investor Relations:

    Michael Bryk

    Vice President, Finance

    Jonathan Fleetwood

    Director, Investor Relations

    [email protected]

    Media Relations:

    Kim Atkinson

    Senior Vice President, Global Communications

    [email protected]

    SmileDirectClub, Inc.

    Consolidated Balance Sheets

    (in thousands, except share and per share amounts)

    (unaudited)

     March 31,

     December 31,

    2023 2022
    ASSETS       
    Cash$59,125  $93,120 
    Accounts receivable, net 135,708   143,082 
    Inventories 40,031   44,387 
    Prepaid and other current assets 16,725   16,830 
    Total current assets 251,589   297,419 
    Restricted cash 27,129   25,278 
    Accounts receivable, net, non-current 47,809   45,168 
    Property, plant and equipment, net 181,739   190,087 
    Operating lease right-of-use assets 18,826   21,141 
    Other assets 18,514   17,970 
    Total assets$545,606  $597,063 
    LIABILITIES AND EQUITY (DEFICIT)       
            
    Accounts payable$34,880  $30,513 
    Accrued liabilities 53,815   65,937 
    Deferred revenue 16,837   13,646 
    Other current liabilities 6,711   6,704 
    Total current liabilities 112,243   116,800 
    Long-term debt, net of current portion 860,197   849,379 
    Operating lease liabilities, net of current portion 14,618   16,082 
    Other long-term liabilities 421   — 
    Total liabilities 987,479   982,261 
    Equity (Deficit)       
    Class A common stock, par value $0.0001 and 130,974,872 shares issued and outstanding at March 31, 2023 and 124,785,562 shares issued and outstanding at December 31, 2022 13   12 
    Class B common stock, par value $0.0001 and 268,623,501 shares issued and outstanding at March 31, 2023 and 268,823,501 shares issued and outstanding at December 31, 2022 27   27 
    Additional paid-in-capital 483,511   475,034 
    Accumulated other comprehensive income 529   430 
    Accumulated deficit (403,144)  (381,725)
    Noncontrolling interest (540,429)  (496,596)
    Warrants 17,620   17,620 
    Total equity (deficit) (441,873)  (385,198)
    Total liabilities and equity (deficit)$545,606  $597,063 

    SmileDirectClub, Inc.

    Consolidated Statements of Operations

    (in thousands, except share and per share amounts)

    (unaudited)

     Three Months Ended March 31,
    2023 2022
    Revenue, net$112,835  $142,512 
    Financing revenue 6,942   9,134 
    Total revenues 119,777   151,646 
    Cost of revenues 32,892   43,066 
    Gross profit 86,885   108,580 
    Marketing and selling expenses 72,201   96,711 
    General and administrative expenses 65,164   70,793 
    Lease abandonment and impairment of long-lived assets 947   1,232 
    Restructuring and other related costs 7,754   11,532 
    Loss from operations (59,181)  (71,688)
    Interest expense 7,709   1,556 
    Other expense (income) (1,484)  1,423 
    Net loss before provision for income tax expense (benefit) (65,406)  (74,667)
    Provision for income tax expense (benefit) 321   (1,463)
    Net loss (65,727)  (73,204)
    Net loss attributable to noncontrolling interest (44,308)  (50,623)
    Net loss attributable to SmileDirectClub, Inc.$(21,419) $(22,581)
       
    Earnings (loss) per share of Class A common stock:  
    Basic$(0.17) $(0.19)
    Diluted$(0.16) $(0.19)
       
    Weighted average shares outstanding:  
    Basic 129,769,504   120,191,790 
    Diluted 398,588,561   389,297,928 

    SmileDirectClub, Inc.

    Consolidated Statements of Cash Flows

    (in thousands)

    (unaudited)

     Three Months Ended March 31,
     2023 2022
    Operating Activities     
    Net loss$(65,727) $(73,204)
    Adjustments to reconcile net loss to net cash used in operating activities:     
    Depreciation and amortization 15,873   18,916 
    Deferred loan cost amortization 1,591   1,078 
    Equity-based compensation 6,630   5,306 
    Paid in kind interest expense 1,227   — 
    Asset impairment and related charges 1,015   1,367 
    Other non-cash operating activities 1,560   1,079 
    Changes in operating assets and liabilities:     
    Accounts receivable 4,733   3,241 
    Inventories 4,288   1,785 
    Prepaid and other current assets (498)  (7,258)
    Accounts payable 4,750   (2,137)
    Accrued liabilities (11,210)  (11,012)
    Deferred revenue 3,191   (425)
    Net cash used in operating activities (32,577)  (61,264)
    Investing Activities     
    Purchases of property, plant and equipment (8,041)  (15,118)
    Net cash used in investing activities (8,041)  (15,118)
    Financing Activities     
    Repurchase of Class A shares to cover employee tax withholdings (638)  (1,847)
    Proceeds from sale of Class A common stock under public offerings 798   — 
    Borrowings of long-term debt 8,000   — 
    Payments of finance leases —   (2,404)
    Other 278   562 
    Net cash provided by (used in) financing activities 8,438   (3,689)
    Effect of exchange rates change on cash flow activities 36   (42)
    Decrease in cash and restricted cash (32,144)  (80,113)
    Cash and restricted cash at beginning of period 118,398   224,860 
    Cash and restricted cash at end of period$86,254  $144,747 

    Use of Non-GAAP Financial Measures

    This earnings release contains certain non-GAAP financial measures, including adjusted EBITDA ("Adjusted EBITDA") and Free Cash Flow. We provide a reconciliation of these non-GAAP financial measures to the most directly comparable GAAP financial measures below and in our Current Report on Form 8-K announcing our quarterly earnings results, which can be found on the SEC's website at www.sec.gov and our website at investors.smiledirectclub.com. We do not provide a reconciliation of forward-looking Adjusted EBITDA to the most directly comparable GAAP financial measure (net loss), as the reconciliation to the corresponding GAAP measure is not available due to the variability, complexity and limited visibility of the non-cash items that are excluded from forward-looking Adjusted EBITDA.

    We utilize certain non-GAAP financial measures, including Free Cash Flow and Adjusted EBITDA, to evaluate our actual operating performance and for the planning and forecasting of future periods.

    We define Free Cash Flow as net cash used in operating activities less net cash used in investing activities.

    We define Adjusted EBITDA as net loss, plus depreciation and amortization, interest expense, income tax expense (benefit), equity-based compensation, loss on extinguishment of debt, impairment of long-lived assets, abandonment and other related charges and certain other non-operating expenses, such as one-time store closure costs associated with our real estate repositioning strategy, severance, retention and other labor costs, certain one-time legal settlement costs, and unrealized foreign currency adjustments. We use Adjusted EBITDA when evaluating our performance when we believe that certain items are not indicative of operating performance. Adjusted EBITDA provides useful supplemental information to management regarding our operating performance, and we believe it will provide the same to members/stockholders.

    We believe that Adjusted EBITDA will provide useful information to members/stockholders about our performance, financial condition, and results of operations for the following reasons: (i) Adjusted EBITDA is among the measures used by our management team to evaluate our operating performance and make day-to-day operating decisions and (ii) Adjusted EBITDA is frequently used by securities analysts, investors, lenders, and other interested parties as a common performance measure to compare results or estimate valuations across companies in our industry.

    Adjusted EBITDA does not have a definition under GAAP, and our definition of Adjusted EBITDA may not be the same as, or comparable to, similarly titled measures used by other companies. Adjusted EBITDA should not be considered in isolation from, or as a substitute for, financial information prepared in accordance with GAAP.

    A reconciliation of Free Cash Flow and Adjusted EBITDA to Net Cash used in operating activities and net loss, respectively, the most directly comparable GAAP financial measures, is set forth below.

    SmileDirectClub, Inc.

    Reconciliation of Free Cash Flow

    (in thousands)

     Three Months Ended
     March 31, 2023December 31, 2022March 31, 2022
    Net Cash used in operating activities$(32,577)$(51,470)$(61,264)
    Net Cash used in investing activities (8,041) (11,828) (15,118)
    Free Cash Flow$(40,618)$(63,298)$(76,382)

    SmileDirectClub, Inc. 

    Reconciliation of Net Loss to Adjusted EBITDA

    (in thousands)

     Three Months Ended
    (in thousands)March 31, 2023December 31, 2022March 31, 2022
    Net loss$(65,727)$(69,431)$(73,204)
    Depreciation and amortization 15,873  16,786  18,916 
    Total interest expense 7,709  6,591  1,556 
    Income tax expense (benefit) 321  (174) (1,463)
    Lease abandonment and impairment of long-lived assets 947  (140) 1,232 
    Restructuring and other related costs 7,754  1,799  11,532 
    Equity-based compensation 6,630  5,049  5,306 
    Other non-operating general and administrative losses (gains) 22  (7,817) 1,684 
    Adjusted EBITDA$(26,471)$(47,337)$(34,441)



    Primary Logo

    Get the next $SDC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SDC

    DatePrice TargetRatingAnalyst
    3/30/2022$2.00Hold → Sell
    Loop Capital
    3/2/2022$2.29 → $2.20Equal-Weight
    Morgan Stanley
    3/2/2022$5.00 → $3.00Equal-Weight
    Stephens & Co.
    1/31/2022$2.29Equal-Weight
    Morgan Stanley
    1/25/2022Sell → Hold
    Craig Hallum
    1/7/2022$11.00 → $4.00Outperform
    Credit Suisse
    11/9/2021$6.00 → $5.00Hold
    Stifel
    11/9/2021$4.00 → $2.00Sell
    Goldman
    More analyst ratings

    $SDC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • SmileDirectClub Seeks to Execute Comprehensive Recapitalization to Strengthen the Business for Sustainable Growth

      NASHVILLE, Tenn., Sept. 29, 2023 (GLOBE NEWSWIRE) -- SmileDirectClub, Inc. (NASDAQ:SDC), the next generation oral care Company with the first medtech platform for teeth straightening, today announced a process to implement a comprehensive recapitalization transaction. The additional capital and stronger financial position from this recapitalization is intended to bolster the Company's balance sheet and fuel growth initiatives to allow SmileDirectClub to thrive as an international oral care leader for many years to come. SmileDirectClub will seek to recapitalize through a transaction where the Company's founders have committed to invest at least $20 million to bolster the Company's balance

      9/29/23 6:31:33 PM ET
      $SDC
      Medical/Dental Instruments
      Health Care
    • SmileDirectClub To Appeal Decision In Align Technology Arbitration

      NASHVILLE, Tenn., Aug. 24, 2023 (GLOBE NEWSWIRE) -- SmileDirectClub (NASDAQ:SDC), the oral care leader and creator of the first med tech platform for teeth straightening, announced its intention to appeal a decision regarding an award of $63 million to be paid to Align Technology following a dispute over the Company's exclusive supply agreement with its former strategic partner. "SmileDirectClub is disappointed with the California trial court's recent rulings denying our Petition to Vacate and granting the Petition to Confirm the Final Award in an arbitration Align brought against SmileDirectClub for alleged breaches of a Supply Agreement between the parties that expired in 2019," said Su

      8/24/23 5:25:00 PM ET
      $SDC
      Medical/Dental Instruments
      Health Care
    • SmileDirectClub Reports Second Quarter 2023 Financial Results

      NASHVILLE, Tenn., Aug. 08, 2023 (GLOBE NEWSWIRE) -- SmileDirectClub, Inc. (NASDAQ:SDC), the next generation oral care company with the first medtech platform for teeth straightening, today announced its financial results for the second quarter ended June 30, 2023. Second Quarter 2023 Financial Highlights Total revenue of $102 million, a 15.0% decrease over the first quarter of 2023 and a decrease of 19.1% over the prior year period. The sequential seasonal decline improved compared to last year despite the first quarter of 2023 overperforming expectations.Net loss improvement of $12 million over the prior year period at $(54) million in the second quarter of 2023.Adjusted EBITDA improvem

      8/8/23 4:01:00 PM ET
      $SDC
      Medical/Dental Instruments
      Health Care

    $SDC
    Financials

    Live finance-specific insights

    See more
    • SmileDirectClub Reports Second Quarter 2023 Financial Results

      NASHVILLE, Tenn., Aug. 08, 2023 (GLOBE NEWSWIRE) -- SmileDirectClub, Inc. (NASDAQ:SDC), the next generation oral care company with the first medtech platform for teeth straightening, today announced its financial results for the second quarter ended June 30, 2023. Second Quarter 2023 Financial Highlights Total revenue of $102 million, a 15.0% decrease over the first quarter of 2023 and a decrease of 19.1% over the prior year period. The sequential seasonal decline improved compared to last year despite the first quarter of 2023 overperforming expectations.Net loss improvement of $12 million over the prior year period at $(54) million in the second quarter of 2023.Adjusted EBITDA improvem

      8/8/23 4:01:00 PM ET
      $SDC
      Medical/Dental Instruments
      Health Care
    • SmileDirectClub to Report Second Quarter 2023 Results on August 8, 2023

      NASHVILLE, Tenn., July 07, 2023 (GLOBE NEWSWIRE) -- SmileDirectClub, Inc. (NASDAQ:SDC), the next generation oral care company with the first medtech platform for teeth straightening, announced today it will report results for the second quarter 2023 on Tuesday, August 8, 2023, after close of market. David Katzman, SmileDirectClub's Chief Executive Officer and Chairman, and Troy Crawford, SmileDirectClub's Chief Financial Officer, will host a conference call to discuss these results on Wednesday, August 9, 2023, at 8 a.m. Eastern Time. SmileDirectClub Second Quarter 2023 Conference Call DetailsDate: Wednesday, August 9, 2023Time: 8 a.m. Eastern Time (7 a.m. Central Time)Dial-In: 1-877

      7/7/23 8:01:00 AM ET
      $SDC
      Medical/Dental Instruments
      Health Care
    • SmileDirectClub Reports First Quarter 2023 Financial Results

      NASHVILLE, Tenn., May 09, 2023 (GLOBE NEWSWIRE) -- SmileDirectClub, Inc. (NASDAQ:SDC), the next generation oral care company with the first medtech platform for teeth straightening, today announced its financial results for the first quarter ended March 31, 2023. Revenue for the first quarter of 2023 increased 38.4% compared to the fourth quarter of 2022 with gross profit up 64.6% for the same period. For the first quarter 2023, disciplined cost management allowed the Company to deliver a $7 million improvement in Net Loss and an $8 million improvement in Adjusted EBITDA compared to the first quarter of 2022 despite a decline in revenue year-over-year. Net Cash used in operating activit

      5/9/23 4:01:00 PM ET
      $SDC
      Medical/Dental Instruments
      Health Care

    $SDC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Wallman Richard F

      4 - SmileDirectClub, Inc. (0001775625) (Issuer)

      6/23/23 4:01:59 PM ET
      $SDC
      Medical/Dental Instruments
      Health Care
    • SEC Form 4 filed by Ward Edward W Iii

      4 - SmileDirectClub, Inc. (0001775625) (Issuer)

      6/5/23 4:23:16 PM ET
      $SDC
      Medical/Dental Instruments
      Health Care
    • SEC Form 4 filed by Williams Linda Marie

      4 - SmileDirectClub, Inc. (0001775625) (Issuer)

      6/5/23 4:22:29 PM ET
      $SDC
      Medical/Dental Instruments
      Health Care

    $SDC
    SEC Filings

    See more
    • SEC Form 25-NSE filed by SmileDirectClub Inc.

      25-NSE - SmileDirectClub, Inc. (0001775625) (Subject)

      12/27/23 9:03:29 AM ET
      $SDC
      Medical/Dental Instruments
      Health Care
    • SmileDirectClub Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits

      8-K - SmileDirectClub, Inc. (0001775625) (Filer)

      10/2/23 5:18:43 PM ET
      $SDC
      Medical/Dental Instruments
      Health Care
    • SmileDirectClub Inc. filed SEC Form 8-K: Bankruptcy or Receivership, Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - SmileDirectClub, Inc. (0001775625) (Filer)

      9/29/23 6:35:50 PM ET
      $SDC
      Medical/Dental Instruments
      Health Care

    $SDC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • SmileDirectClub downgraded by Loop Capital with a new price target

      Loop Capital downgraded SmileDirectClub from Hold to Sell and set a new price target of $2.00

      3/30/22 7:52:04 AM ET
      $SDC
      Medical/Dental Instruments
      Health Care
    • Morgan Stanley reiterated coverage on SmileDirectClub with a new price target

      Morgan Stanley reiterated coverage of SmileDirectClub with a rating of Equal-Weight and set a new price target of $2.20 from $2.30 previously

      3/2/22 10:22:00 AM ET
      $SDC
      Medical/Dental Instruments
      Health Care
    • Stephens & Co. reiterated coverage on SmileDirectClub with a new price target

      Stephens & Co. reiterated coverage of SmileDirectClub with a rating of Equal-Weight and set a new price target of $3.00 from $5.00 previously

      3/2/22 7:21:27 AM ET
      $SDC
      Medical/Dental Instruments
      Health Care

    $SDC
    Leadership Updates

    Live Leadership Updates

    See more
    • Holley Announces Appointment of Jesse Weaver as Chief Financial Officer

      Holley Inc. (NYSE:HLLY), the leading platform serving performance automotive enthusiasts, today announced the appointment of Jesse Weaver as the Company's Chief Financial Officer. Mr. Weaver will succeed Stephen Trussell, who has served as the Company's Interim Chief Financial Officer since September 30, 2022. Mr. Trussell will continue as the Company's Vice President of Finance, a role he has held since 2009. Mr. Weaver, who has nearly 20 years of experience in finance, strategy, and data analytics, will serve as a member of the executive leadership team and report directly to President and Chief Executive Officer, Tom Tomlinson. Most recently, Mr. Weaver served as Senior Vice President o

      12/12/22 4:01:00 PM ET
      $DG
      $HLLY
      $SDC
      $YUM
      Department/Specialty Retail Stores
      Consumer Discretionary
      Auto Parts:O.E.M.
      Medical/Dental Instruments
    • SmileDirectClub Appoints Azmat Ali as Vice President of Product

      NASHVILLE, Tenn., Oct. 10, 2022 (GLOBE NEWSWIRE) -- SmileDirectClub, Inc. (NASDAQ:SDC), the next generation oral care company with the first medtech platform for teeth straightening, today announced the appointment of Azmat Ali as Vice President of Product. Mr. Ali will play a significant role in enhancing the customer experience by fueling the Company's innovation portfolio with high-quality aligners, retainers, and new opportunities that complement the Company's existing offerings. Mr. Ali is a results-driven product marketing executive with experience leading organizations through change and growth. As VP of Product, he will own the product vision, roadmap, and customer experience fo

      10/10/22 8:00:00 AM ET
      $SDC
      Medical/Dental Instruments
      Health Care
    • SmileDirectClub Announces Appointment of Alex Dimitrief to Board of Directors

      NASHVILLE, Tenn., July 25, 2022 (GLOBE NEWSWIRE) -- SmileDirectClub, Inc. (NASDAQ:SDC), the next generation oral care company with the first medtech platform for teeth straightening, today announced the appointment of Alex Dimitrief as an independent director on its Board of Directors, effective immediately. Mr. Dimitrief is an experienced director and C-suite leader with a track record of steering global businesses through a wide range of challenges. He currently serves as a Partner at Zeughauser Group, a Lecturer on Law at Harvard Law School, and a Senior Fellow and Distinguished Adjunct Professor at the New York Law School. From 2007 to 2019, Mr. Dimitrief served in several business

      7/25/22 8:01:00 AM ET
      $EOSE
      $SDC
      Industrial Machinery/Components
      Miscellaneous
      Medical/Dental Instruments
      Health Care

    $SDC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by SmileDirectClub Inc. (Amendment)

      SC 13G/A - SmileDirectClub, Inc. (0001775625) (Subject)

      2/14/23 4:00:19 PM ET
      $SDC
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G filed by SmileDirectClub Inc.

      SC 13G - SmileDirectClub, Inc. (0001775625) (Subject)

      3/2/22 4:00:29 PM ET
      $SDC
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by SmileDirectClub Inc. (Amendment)

      SC 13G/A - SmileDirectClub, Inc. (0001775625) (Subject)

      2/10/22 8:37:48 AM ET
      $SDC
      Medical/Dental Instruments
      Health Care